Novacyt Company Description

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa.

It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases.

The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine.

The company was incorporated in 2006 and is based in Eastleigh, the United Kingdom.

Novacyt S.A.

Country	France
Founded	2006
Industry	Medical Devices
Sector	Healthcare
Employees	237
CEO	Lyn Rees

Contact Details

Address: York House Eastleigh, SO53 4DG United Kingdom
Phone	44 2380 748830
Website	novacyt.com

Stock Details

Ticker Symbol	ALNOV
Exchange	Euronext Paris
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	FR0010397232
SIC Code	2835

Key Executives

Name	Position
Lyn Dafydd Rees	Chief Executive Officer and Executive Director
Steve Gibson	Chief Financial Officer and Director
Bryan Close	Chief Operations Officer
Dr. Joanne Mason	Chief Scientific Officer and Director
David Franks	Chief Human Resources Officer
Paul Oladimeji	Group Head of Research & Development